Recent advances of circular RNAs as biomarkers for osteosarcoma

H Wu, S Zheng, Q He, Y Li - International Journal of General …, 2023 - Taylor & Francis
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …
被引用次数：6 相关文章

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

H Wu, S Zheng, Q He, Y Li - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

H Wu, S Zheng, Q He, Y Li - International Journal of General …, 2023 - dovepress.com
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …

[引用][C] Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

H Wu, S Zheng, Q He, Y Li - International Journal of General …, 2023 - europepmc.org
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …
[HTML] nih.gov

[HTML][HTML] Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

H Wu, S Zheng, Q He, Y Li - International Journal of General …, 2023 - ncbi.nlm.nih.gov
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

H Wu, S Zheng, Q He, Y Li - International Journal of General …, 2023 - search.proquest.com
Osteosarcoma is the most common primary malignant bone tumor in young adult, which is
prone to early metastasis and poor prognosis. The current treatment methods need to be …